← Human Trials & Peer-Reviewed Studies

Effect of Cashew Nut Consumption on Biomarkers of Copper and Zinc Status in Adolescents with Obesity: A Randomized Controlled Trial.

Plain-language guide to PMID 39796597 (2024): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc and Copper (Supplement).

Key Facts

PMID
39796597
Journal
Nutrients
Year
2024
Study type
Randomized Controlled Trial
Authors
Dias TDS et al. (12 authors)
DOI
10.3390/nu17010163

What This Study Did, in Plain Language

What Was Tested

This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc and Copper (Supplement).

To evaluate the effects of cashew nut consumption on biomarkers of Cu and Zn status in adolescents with obesity.

Who Took Part

PubMed indexes the participants as children and teenagers, both men and women.

The participants were divided into a control group (CON) and a cashew nut group (CASN).

How the Study Was Run

The design is described as randomized.

The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

This was a randomized controlled trial conducted in adolescents.

Anthropometric, dietary, and biochemical parameters (Zn, Cu, and superoxide dismutase (SOD)) were assessed at the baseline and at the end of the study.

Association tests, within-group and between-group mean comparisons, and analyses of variation between study periods (Δ T12-T0) were performed.

What Was Measured

PubMed files the paper under topics including Zinc, Anacardium, Copper, Biomarkers, Pediatric Obesity, Nuts and Nutritional Status.

Author keywords: micronutrients, minerals, regional food and superoxide dismutase.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc and Copper (Supplement).

Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2024 (Nutrients), a journal based in Switzerland.

More context: the Vitamin D, K2, Magnesium and Zinc compound page and the Copper (Supplement) compound page, all human trials.

Our Notes on the Compounds

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.